As of Mar 21
| +0.15 / +0.77%|
The 10 analysts offering 12-month price forecasts for AMAG Pharmaceuticals Inc have a median target of 17.00, with a high estimate of 22.00 and a low estimate of 12.00. The median estimate represents a -13.49% decrease from the last price of 19.65.
The current consensus among 11 polled investment analysts is to Hold stock in AMAG Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.